Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

Jacobson, IM; Lawitz, E; Gane, EJ; Willems, BE; Ruane, PJ; Nahass, RG; Borgia, SM; Shafran, SD; Workowski, KA; Pearlman, B; Hyland, RH; Stamm, LM; Svarovskaia, E; Dvory-Sobol, H; Zhu, Y; Subramanian, GM; Brainard, DM; McHutchison, JG; Brau, N; Berg,

Jacobson, IM (reprint author), NYU Langone Med Ctr, Dept Med, 550 First Ave, New York, NY 10016 USA.

GASTROENTEROLOGY, 2017; 153 (1): 113

Abstract

BACKGROUND & AIMS: Patients with chronic hepatitis C virus (HCV) infection have high rates of sustained virologic response (SVR) after 12 weeks of......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索